- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Ablynx NV+ Add to Watchlist
4AY:GR10.430 EUR 0.580 5.89%
As of 07:54:28 ET on 01/26/2015.
Company Profile for Ablynx NV (4AY)
Ablynx NV is a biopharmaceutical company. The Company discovers and develops therapeutic protein treatments for human diseases.
Key Executives for Ablynx NV (4AY)
|Edwin MosesChief Executive Officer||Wim OttevaereChief Financial Officer|
|Johan HeylenChief Commercial Officer||Josefin-Beate Holz "Josi"Chief Medical Officer|
|Marieke VermeerschAssociate Dir:Investor Relations|